Autologous hematopoietic stem cell transplantation for multiple myeloma in the age of CAR T cell therapy

Chimeric antigen receptor (CAR) T cell therapy has revolutionized the management of relapsed and refractory myeloma, with excellent outcomes and a tolerable safety profile. High dose chemotherapy with autologous hematopoietic stem cell transplantation (AHCT) is established as a mainstream of newly d...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Charlotte F. M. Hughes, Gunjan L. Shah, Barry A. Paul
التنسيق: مقال
اللغة:English
منشور في: Frontiers Media S.A. 2024-03-01
سلاسل:Frontiers in Oncology
الموضوعات:
الوصول للمادة أونلاين:https://www.frontiersin.org/articles/10.3389/fonc.2024.1373548/full